Broccoli Microgreens — The Science
The Most Studied Plant Compound in the World. Delivered at Its Biological Peak.
Why broccoli microgreens are not just a more concentrated vegetable — and what the science actually shows about what they do in the body.
Why Broccoli Is Different
Broccoli and other cruciferous vegetables occupy a unique position in nutritional science because they produce a specific class of compounds — glucosinolates — that interact with the body's regulatory systems in ways that most other foods simply do not. Broccoli is one of the richest dietary sources of glucosinolates in the world, and the compounds they produce — particularly isothiocyanates like sulforaphane — interact with cellular signaling pathways involved in antioxidant defense, detoxification, inflammatory regulation, and stress resilience.
These are not passive nutrients the body uses as building blocks. They are signals that communicate with the body at a genetic level, influencing which protective systems are expressed more strongly and which inflammatory pathways are dialed down.
The research is not primarily about broccoli's vitamin C content or fiber. It is about what glucosinolates and their derivatives do once they enter the body — and the evidence, across hundreds of peer-reviewed studies and multiple human clinical trials, is compelling.
Glucoraphanin and the Seedling Advantage
The most important glucosinolate in broccoli is glucoraphanin — the direct precursor to sulforaphane. Broccoli microgreens contain glucoraphanin at concentrations up to 100 times higher per gram than mature broccoli. A 3oz serving of broccoli microgreens contains the glucoraphanin equivalent of approximately 14 heads of mature broccoli. But concentration and active myrosinase — the enzyme that converts glucoraphanin into sulforaphane — both need to be present. Fresh microgreens have both.
During the seedling stage, the plant's chemical defense system is operating at peak intensity. The young plant has no thick cuticle, no established root system, and no structural defenses to rely on — so it concentrates its protective chemistry into a small amount of tissue at levels far higher than it will ever produce again. As the plant matures, energy shifts toward structural development and biomass, and glucoraphanin concentration per gram dilutes accordingly.
The window in which broccoli is most glucoraphanin-dense is narrow. Microgreens are harvested directly inside that window. Mature broccoli is harvested well outside it.
By the time commercially sold broccoli has been harvested, handled, transported, and stored for one to three weeks, myrosinase activity has declined significantly — meaning most of the glucoraphanin never converts to sulforaphane at all. Fresh broccoli microgreens delivered within 24 hours arrive with both glucoraphanin at peak concentration and myrosinase fully active — the combination that makes efficient sulforaphane production possible.
The Science in Depth
The mechanisms behind what broccoli microgreens do in the body are well studied and increasingly well understood. Each section below covers a distinct piece of that picture.
Sulforaphane is the most studied compound in broccoli, but broccoli microgreens produce a broader family of glucosinolates that convert into different isothiocyanates and indole compounds, each interacting with the body through distinct but complementary pathways.
Broccoli microgreens also contain glucoerucin, which converts to erucin — a structural relative of sulforaphane that shares many of its detoxification and anti-inflammatory properties and works synergistically alongside it. Glucobrassicin converts to indole-3-carbinol and its derivative DIM in the gut — compounds that interact with hormone metabolism, immune regulation, and cellular detoxification through pathways that sulforaphane does not directly address. Additional glucosinolates including gluconapin and glucocheirolin contribute further to the spectrum of isothiocyanate activity.
Different isothiocyanates interact with different cellular targets — meaning the body receives multiple overlapping signals simultaneously rather than a single concentrated input. Some compounds enhance the bioavailability of others. Some activate pathways that make companion compounds more effective. The full spectrum of glucosinolates in fresh broccoli microgreens is significantly broader than what any supplement or extract can replicate.
Sulforaphane is the headline. But it arrives as part of a system — and that system is what makes fresh broccoli microgreens genuinely different from anything in a capsule.
Inside a living broccoli plant, glucoraphanin and myrosinase are stored separately — compartmentalized within different cellular structures so they never come into contact while the plant is intact. The plant keeps its chemical defense in a locked form and releases it only when tissue is damaged — at which point the two compounds combine and sulforaphane is produced as part of its stress response.
When you chew or cut fresh broccoli microgreens, you trigger that same mechanism. Cell walls rupture, glucoraphanin and myrosinase come into contact, and sulforaphane is produced. The conversion happens rapidly and efficiently when myrosinase is active — research suggests approximately 30–40% of available glucoraphanin converts to sulforaphane under these conditions.
Myrosinase is extremely sensitive to heat and time. Cooking broccoli — even lightly — significantly reduces myrosinase activity, which is why cooked broccoli produces far less sulforaphane than raw. Freshness at delivery is not a preference — it is a prerequisite for getting the most out of what broccoli microgreens contain.
Sulforaphane does not neutralize free radicals directly. It activates the system that produces the body's own antioxidant and detoxification machinery.
Under normal conditions, a protein called Keap1 keeps Nrf2 — a master regulatory molecule — held in check in the cytoplasm, targeting it for continuous degradation. Sulforaphane modifies key sensor sites on Keap1 in a way that disrupts this restraint. Nrf2 accumulates, moves into the nucleus, and binds to antioxidant response elements in DNA — sequences that control the activity of a large network of protective genes.
The downstream effects are significant. Nrf2 activation increases production of glutathione and its related enzymes — the primary redox buffer inside cells. It upregulates superoxide dismutase and catalase, the enzymes responsible for neutralizing the most common forms of reactive oxygen species. It increases Phase II detoxification enzymes including glutathione S-transferases, NQO1, and glucuronosyltransferases — responsible for conjugating and clearing reactive compounds from the body.
Nrf2 also suppresses NF-κB — the master controller of inflammatory gene expression — reducing production of pro-inflammatory signaling molecules like TNF-α and IL-6. Sulforaphane is not simply turning protective systems on. It is simultaneously turning inflammatory systems down. Both effects are coordinated through the same signaling cascade.
Dietary antioxidants neutralize reactive molecules one at a time and are consumed in the process. Sulforaphane communicates with the cell's own regulatory system — activating defenses that are reusable, scalable, and self-sustaining, while reducing the inflammatory signals that compound cellular stress over time.
Sulforaphane works partly through a principle called hormesis — where a mild, controlled stress signal triggers a stronger and more resilient biological response. Resistance training is the clearest example most people are familiar with — controlled physical stress damages muscle fibers, which triggers repair and adaptation that leaves muscles stronger than before. The stress is not the benefit. The adaptation it triggers is.
Sulforaphane operates through a similar principle. It is a mild electrophile — a chemically reactive molecule that interacts with sensor proteins inside cells, including Keap1, in a way the cell interprets as a stress signal. In response, Nrf2 is activated and the cell upregulates its protective systems — producing more antioxidant enzymes, more detoxification capacity, and greater resilience to future stress.
At low to moderate doses, this hormetic response is the core mechanism behind sulforaphane's biological effects. The compound is not directly neutralizing damage or supplementing missing nutrients. It is signaling the cell to prepare — to run its own defense systems at higher capacity in anticipation of stress.
Single large doses are less effective than consistent smaller doses over time, because the adaptation sulforaphane triggers is cumulative. The more regularly the body receives the signal, the more capable its defense systems become at responding to it. Consistent stimulus, consistent adaptation, compounding resilience over time — the same principle as progressive overload in training.
When broccoli microgreens are eaten, glucobrassicin and related indole glucosinolates are broken down in the gut into indole-3-carbinol, which further converts to DIM — diindolylmethane — during digestion. These compounds bind to and activate the aryl hydrocarbon receptor, or AhR, a regulatory protein found throughout the gut, liver, immune tissue, and skin.
AhR is not as well known as Nrf2 but it is equally important as a dietary sensing system. When activated by indole compounds from broccoli, it regulates genes involved in Phase I and Phase II detoxification — helping the body process environmental compounds, hormones, and metabolic byproducts. It plays a significant role in immune tolerance, helping the immune system distinguish between threats that require a response and normal inputs that do not. And it supports gut barrier integrity — the structural lining that determines what passes from the digestive system into circulation.
AhR activation from dietary indoles happens simultaneously with Nrf2 activation from sulforaphane. Two major regulatory pathways — one governing antioxidant and detoxification defense, one governing immune modulation and gut barrier function — activated by the same food at the same time. Isolated supplements structurally cannot replicate this.
The Human Trial Evidence
Human clinical research on sulforaphane and broccoli sprout preparations has produced some of the most compelling evidence available for any dietary compound. Randomized controlled trials in human populations, using broccoli-derived compounds at food-relevant doses, across detoxification, cancer biomarkers, metabolic health, cognition, and physical performance.
Han's Greens broccoli microgreens are not a medical treatment and make no claims to treat or cure any condition. They deliver the same class of compounds used in these trials, in a fresh whole food form, at concentrations that mature broccoli and most supplements cannot match.
How to Eat Broccoli Microgreens for Maximum Sulforaphane
Safety and Thyroid — Addressing the Common Question
Cruciferous vegetables contain compounds called goitrogens — primarily indole glucosinolates and their derivatives — that can in theory interfere with thyroid hormone synthesis by limiting iodine uptake. This effect is real in specific contexts: primarily in populations with severe iodine deficiency or in people consuming extremely high doses of concentrated cruciferous extracts over extended periods.
At normal dietary intake levels — including daily consumption of fresh broccoli microgreens — the evidence does not support meaningful thyroid risk for most people. A 12-week randomized controlled trial that specifically monitored thyroid hormone levels and autoimmune thyroid markers in participants consuming broccoli sprout beverages found no adverse effects on thyroid function across the intervention period.
People with existing thyroid conditions, particularly hypothyroidism or autoimmune thyroid disease, should discuss significant increases in cruciferous vegetable consumption with their healthcare provider. For most healthy individuals, daily consumption of fresh broccoli microgreens at normal serving sizes presents no thyroid concern based on available evidence.
Why Broccoli Is 50% of Every Box
The decision to anchor every curated box at 50% broccoli comes directly from the research. The human trial evidence for sulforaphane is built almost entirely around consistent, daily exposure. The hormetic mechanism that makes sulforaphane effective depends on regular signaling — Nrf2 responds to repeated activation over time, building a more resilient cellular defense system the more consistently it receives the signal to upregulate.
The remaining 50% is not filler. Sunflower, radish, mustard, and the other varieties in each box contribute polyphenols, flavonoids, nitrates, carotenoids, and organosulfur compounds that work through different pathways and broaden the biological effect of every serving.
A 3oz box of Han's Greens broccoli microgreens delivers the glucoraphanin equivalent of approximately 14 heads of mature store-bought broccoli — roughly $56 worth of grocery store produce at local NoVA prices, for $9. That comparison does not account for the significantly reduced myrosinase activity in commercial broccoli, the weeks of storage and transport that further reduce glucoraphanin conversion, or the 24-hour freshness window that makes Han's Greens microgreens biologically active in a way that store broccoli simply is not.
Broccoli is the anchor. That will not change.
Harvested and Delivered Within 24 Hours.
No commitment required. The same compounds used in these trials, delivered fresh and at their biological peak.
References
- Fahey JW et al. PNAS, 1997.
- Fahey JW et al. PNAS, 1997.
- Verkerk R et al. Journal of Functional Foods, 2009.
- Halkier BA & Gershenzon J. Annual Review of Plant Biology, 2006.
- Matusheski NV et al. Journal of Agricultural and Food Chemistry, 2004.
- Dinkova-Kostova AT & Talalay P. Molecular Nutrition & Food Research, 2008.
- Hoesel B & Schmid JA. Molecular Cancer, 2013.
- Calabrese EJ et al. Critical Reviews in Toxicology, 2010.
- Rothhammer V & Quintana FJ. Nature Reviews Immunology, 2019.
- Egner PA et al. Cancer Prevention Research, 2014.
- Verhagen H et al. Cancer Letters, 1995.
- Alumkal JJ et al. Investigational New Drugs, 2015.
- Axelsson AS et al. Science Translational Medicine, 2017.
- Sungwon K et al. Molecular Nutrition & Food Research, 2021.
- Sun Y et al. Physiological Reports, 2021.
- Bahadoran Z et al. International Journal of Food Sciences and Nutrition, 2012.